47 related articles for article (PubMed ID: 37354712)
21. [Deodorants and antiperspirants].
Martini MC
Ann Dermatol Venereol; 2020 May; 147(5):387-395. PubMed ID: 32248967
[TBL] [Abstract][Full Text] [Related]
22. Correlation between daily life aluminium exposure and breast cancer risk: A systematic review.
Moussaron A; Alexandre J; Chenard MP; Mathelin C; Reix N
J Trace Elem Med Biol; 2023 Sep; 79():127247. PubMed ID: 37354712
[TBL] [Abstract][Full Text] [Related]
23. [The use of deodorants/antiperspirants does not constitute a risk factor for breast cancer].
Namer M; Luporsi E; Gligorov J; Lokiec F; Spielmann M
Bull Cancer; 2008 Sep; 95(9):871-80. PubMed ID: 18829420
[TBL] [Abstract][Full Text] [Related]
24. Breast Cancer and Deodorants/Antiperspirants: a Systematic Review.
Allam MF
Cent Eur J Public Health; 2016 Sep; 24(3):245-247. PubMed ID: 27755864
[TBL] [Abstract][Full Text] [Related]
25. The effect of antiperspirant and deodorant use on acute radiation dermatitis in breast cancer patients during radiotherapy: a systematic review and meta-analysis.
Salvestrini V; Marta GN; Caini S; Wolf JR; van den Hurk C; Beveridge M; Lam H; Bonomo P; Chow E; Behroozian T
Support Care Cancer; 2023 Mar; 31(3):198. PubMed ID: 36867303
[TBL] [Abstract][Full Text] [Related]
26. If exposure to aluminium in antiperspirants presents health risks, its content should be reduced.
Pineau A; Fauconneau B; Sappino AP; Deloncle R; Guillard O
J Trace Elem Med Biol; 2014 Apr; 28(2):147-150. PubMed ID: 24418462
[TBL] [Abstract][Full Text] [Related]
27. Deodorant use and breast cancer risk.
Hardefeldt PJ; Edirimanne S; Eslick GD
Epidemiology; 2013 Jan; 24(1):172. PubMed ID: 23232621
[No Abstract] [Full Text] [Related]
28. Aluminium and the human breast.
Darbre PD
Morphologie; 2016 Jun; 100(329):65-74. PubMed ID: 26997127
[TBL] [Abstract][Full Text] [Related]
29. Aluminium and breast cancer: Sources of exposure, tissue measurements and mechanisms of toxicological actions on breast biology.
Darbre PD; Mannello F; Exley C
J Inorg Biochem; 2013 Nov; 128():257-61. PubMed ID: 23899626
[TBL] [Abstract][Full Text] [Related]
30. Deodorants and antiperspirants: New trends in their active agents and testing methods.
Teerasumran P; Velliou E; Bai S; Cai Q
Int J Cosmet Sci; 2023 Aug; 45(4):426-443. PubMed ID: 36896776
[TBL] [Abstract][Full Text] [Related]
31. Use of deodorants during adjuvant breast radiotherapy: a survey of compliance with standard advice, impact on patients and a literature review on safety.
Graham PH; Graham JL
J Med Imaging Radiat Oncol; 2009 Dec; 53(6):569-73. PubMed ID: 20002290
[TBL] [Abstract][Full Text] [Related]
32. Does antiperspirant use increase the risk of aluminium-related disease, including Alzheimer's disease?
Exley C
Mol Med Today; 1998 Mar; 4(3):107-9. PubMed ID: 9575492
[TBL] [Abstract][Full Text] [Related]
33. EEMCO guidance for the efficacy assessment of antiperspirants and deodorants.
Piérard GE; Elsner P; Marks R; Masson P; Paye M;
Skin Pharmacol Appl Skin Physiol; 2003; 16(5):324-42. PubMed ID: 12907837
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies.
Gennari A; Costa M; Puntoni M; Paleari L; De Censi A; Sormani MP; Provinciali N; Bruzzi P
Breast Cancer Res Treat; 2015 Apr; 150(2):405-13. PubMed ID: 25744295
[TBL] [Abstract][Full Text] [Related]
35. Do underarm cosmetics cause breast cancer?
Gikas PD; Mansfield L; Mokbel K
Int J Fertil Womens Med; 2004; 49(5):212-4. PubMed ID: 15633477
[TBL] [Abstract][Full Text] [Related]
36. Aluminium in cosmetics and personal care products.
Sanajou S; Şahin G; Baydar T
J Appl Toxicol; 2021 Nov; 41(11):1704-1718. PubMed ID: 34396567
[TBL] [Abstract][Full Text] [Related]
37. Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review.
Segnan N; Minozzi S; Armaroli P; Cinquini M; Bellisario C; González-Lorenzo M; Gianola S; Ponti A
Int J Cancer; 2016 Aug; 139(3):554-73. PubMed ID: 27004723
[TBL] [Abstract][Full Text] [Related]
38. An unexpected link: The role of mammary and gut microbiota on breast cancer development and management (Review).
Toumazi D; El Daccache S; Constantinou C
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786630
[TBL] [Abstract][Full Text] [Related]
39. Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.
Schlotter CM; Tietze L; Vogt U; Heinsen CV; Hahn A
Horm Mol Biol Clin Investig; 2017 Sep; 32(2):. PubMed ID: 28937963
[TBL] [Abstract][Full Text] [Related]
40. A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.
Pennant M; Takwoingi Y; Pennant L; Davenport C; Fry-Smith A; Eisinga A; Andronis L; Arvanitis T; Deeks J; Hyde C
Health Technol Assess; 2010 Oct; 14(50):1-103. PubMed ID: 21044553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
